1. Overview
The Harvard Molecular Diagnostics: Current Roles in Cancer Diagnosis 2026 program provides a comprehensive exploration of the latest advancements and practical applications in molecular oncology. The course covers critical topics such as Next-Generation Sequencing (NGS) pipelines, bioinformatics, liquid biopsies, and tumor-specific molecular markers, empowering practitioners to enhance precision medicine and diagnostic accuracy in clinical settings.
Course Date: April 13, 2026 – April 15, 2026
2. Learning Objectives
Explain the fundamental principles and methodologies of molecular diagnostics relevant to cancer care.
Interpret and apply molecular test results to guide diagnosis, prognosis, and therapeutic decision-making.
Communicate molecular test findings effectively within interdisciplinary care teams and with patients.
Evaluate the practical considerations of molecular testing, including test selection, cost, and access.
Integrate recent advances in molecular oncology into clinical practice to improve patient-centered outcomes.
3. Target Audience
Best for pathologists, oncologists, and laboratory directors who want updates on NGS, liquid biopsy, and advanced molecular cancer diagnostics.
4. Topics
01 Integrated Molecular Oncology in 2026 Trends and Tools for Gene Fusion Detection
02 End-to-end Process to Accelerating Treatment Initiation with Next-day NGS
03 Translation of Molecular to Immunohistochemistry
04 Informatics Architecture
05 NGS Pipelines Demystified Practical Bioinformatics
06 Tumor Mutation Burden, MSI, and HRD
07 Indel Detection
08 Viral Sequence Detection and Other Signatures
09 Gene Fusion Detection and Interpretation by RNA-based NGS a Practical, Cased-based Approach
10 Additional Informatics Analyses Detection of Clinically Significant Isoforms and Sub-gene Events through RNA andor DNA-based NGS
11 Oncogenicity Interpretation of Gene Fusions Detected by RNA-based NGS
12 Applications of Long-Read Sequencing for Cancer Diagnostics
13 Liquid Biopsy and ctDNA Technical and Clinical Perspectives
14 Panel Discussion Tissue vs Liquid Biopsy
15 Sarcoma and Fusion Testing
16 Molecular Diagnostics for GYN Tumors
17 Molecular Diagnostics for Pediatric Tumors
18 GU Cancers Molecular Markers (Only PDF, No Video)
19 Copy Number Variation via NGS and Microarray
20 Cytogenomics Technical Focus
21 Cytogenomics Clinical Focus
22 Gliomas and Methylation Profiling
23 Germline Testing in Oncology What, When, and How
24 Tumor-Normal Paired Sequencing Clinical Impact
25 Case Review Pathology Oncology Perspectives
26 Melanoma Molecular Pathology
27 Molecular Diagnostics for Breast Cancer
28 Tumor Board Simulation Real Case Review
29 Myeloid Neoplasms and MRD Testing
30 Leukemia Molecular Diagnostics (B- and T-cell)
31 Molecular Diagnostics and Lymphoma
32 Pharmacogenomics in Oncology Management
33 Lung Tumor Testing
GI Cancer Case-Based Applications VIDEO + PDF Not Release
35 Thyroid Cancer and Salivary Tumor Genomics
36 AI in Molecular Oncology
37 Interactive Workshop Case Report Writing and Communication
38 The Power of Patient Partnership in Cancer Advocacy
39 Building a Molecular Profiling Program
40 Regulatory and Reimbursement Essentials
41 Lab Leadership and Challenges
42 Future Directions in Molecular Oncology




Reviews
There are no reviews yet.